SPIA
PRME icon

Steward Partners Investment Advisory’s Prime Medicine PRME Stock Holding History

Steward Partners Investment Advisory’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$409K Sell
117,456
-950
-0.8% -$3.62K ﹤0.01% 1618
2025
Q4 		$411K Sell
118,406
-7,981
-6% -$35.5K ﹤0.01% 1534
2025
Q3 		$700K Buy
+126,387
New +$513K ﹤0.01% 1212

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Steward Partners Investment Advisory's PRME Position: Q1 2026 in Review

Steward Partners Investment Advisory reduced its Prime Medicine (PRME) stake by 0.8% in Q1 2026, selling an estimated $3.62K and leaving 117,456 shares worth $409K. The position accounts for ﹤0.01% of the portfolio, ranked #1618.

Steward Partners Investment Advisory first reported a position in PRME in Q3 2025 and has held it in 3 quarters since. The position peaked at $700K in Q3 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Steward Partners Investment Advisory held 117,456 shares of Prime Medicine worth $409K as of Q1 2026.
  • Steward Partners Investment Advisory sold 950 Prime Medicine shares in Q1 2026, an estimated $3.62K.
  • Prime Medicine made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #1618 holding.
  • Steward Partners Investment Advisory first reported a position in Prime Medicine in Q3 2025 and has held it in 3 quarters since.
  • Steward Partners Investment Advisory's Prime Medicine position peaked at $700K in Q3 2025.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.